District Court of Delaware rules that Actavis does not infringes with their Suboxone® and Subutex® generics
Opioid Use Disorder Market Is Booming Worldwide 2023-2030 | Indivior PLC, Alkermes, Orexo AB, Titan Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd. - Digital Journal
Orexo sues Actavis and Teva over narcotic dependency treatment
Opioid Use Disorder Market Growth to register a CAGR of 8.7% to reach USD US$ 4,911.8 Million by 2028 | Indivior PLC, Alkermes, Orexo AB, Titan Pharmaceuticals, | Medgadget
Teva unloads plant, U.S. OTC line to PL Developments | Fierce Pharma
Teva extends global rebrand with tailored marketing messages for caregivers | Fierce Pharma
Type headline here
In opioid case, NY wants to probe Teva's control of Teva USA
Suboxone sales down as opioid addiction drug market intensifies
Type headline here
Patent Litigation Updates: CRISPR, Acorda's Ampyra, and Orexo Versus Teva | BioSpace
Teva Seeks to Consolidate Price-Fixing, Opioid Lawsuits
Teva, denying 'any liability,' set aside $646M for opioid settlements. Here's why | Fierce Pharma
Orexo seeks approval of nasal high-dose opioid rescue medicine
Orexo AB - Org Chart, Teams, Culture & Jobs | The Org
Teva Can Challenge Validity of Orexo Patent (Corrected)
Teva kept quiet for weeks on forthcoming generics blow: report | Fierce Pharma
Swedish Pharmaceutical Company: Orexo soars after winning opioid drug appeal against Teva, Health News, ET HealthWorld
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE OREXO AB and OREXO US, INC., Plaintiffs, ACTA VIS ELIZABETH LLC
Opioid Use Disorder Market Analysis to 2027 - Hikma Pharmaceuticals, Teva Pharmaceuticals, MediciNova, Orexo, Camurus, Omeros
Orexo launches digital therapies for depression, alcohol misuse early in US | pharmaphorum
Orexo enters patent infringement litigation against Actavis
OREXO AB (PUBL)
Annual Report
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE OREXO AB and OREXO US, INC., Plaintiffs, ACTAVIS ELIZABETH LLC,
